Par Drugs And Chemicals Limited has informed the Exchange about General Updates
PAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Par Drugs and Chemicals Limited disclosed a GST audit order received from the Office of Joint Commissioner of State Tax, Bhavnagar, Gujarat. The audit covered FY 2021-22 and FY 2022-23 and was conducted under Section 65 of the GGST/CGST Act, 2017, resulting in Form GST ADT-02 being issued. Importantly, the company stated that no violation or contravention was found under Section 65 and no tax demand has been raised against the company. The company also confirmed that it had filed documents and paid taxes on time during the audit period. Management has assessed this order as having no material impact on the financials, operations, or other activities of the company.
This is a neutral disclosure for shareholders — the GST audit was completed without any penalty, demand, or adverse finding. There is no expected negative impact on earnings or operations from this order.